David Johnston CFO Male • United States of America

As a former CFO, David Johnston was an accomplished finance professional with decades of experience in the life sciences industry. He has held senior-level finance positions since 1998, starting as senior vice president of corporate finance, corporate planning, and analysis for Genzyme. Following that, he served as CFO for two Boston-based multinationals working on cancer treatments. Before joining the biotech industry, he also worked in financial roles in other industries.


In addition to his professional experience, he is a prolific writer and blogger. He frequently writes about topics related to biotechnology and finance, with his work appearing on Medium, Tumblr, the Buckeye Business Review, DrBioScience, and other online business and medical sites.


With his extensive experience and skills, Johnston provides invaluable assistance to clients of dbj Consulting. His expertise includes leading initial public offerings, advising startups on how to raise funding and plan their financial future, managing SEC reporting and financial analysis, developing and rethinking capital allocation strategies, improving operational efficiencies by analyzing bottlenecks, and helping companies use financial data to make decisions.


He has won numerous awards for his financial and strategic insight, which he draws on to help his clients succeed. He is skilled at creating non-dilutive royalty financing, advising companies on strategic stock buy and sell solutions, investor relations, corporate finance, strategic planning, and setting key performance indicators (KPIs), financial modeling, mergers and acquisitions, acquisition integration, revenue recognition, due diligence, and navigating the Sarbanes-Oxley Act.


Johnston's unique blend of experience, expertise, and written work make him an invaluable asset to any client seeking financial guidance and strategic advice in the life sciences industry.